Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Moptim

Explore full profile

A global medical technology innovator committed to introduce high technology and ophthalmic product solution at affordable price

Shenzhen, ChinaFounded 2003Health Tech & Medtech
Valuation $50–100M Last recorded · 2026
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Moptim and the history behind them.

About Moptim

Moptim, a name derived from "Medical Optical Imaging," was established in 2003 by Mr. Hui Wang and scientists from Tsinghua University's inaugural Optical Coherence Tomography (OCT) research group. The firm operates in the global medical technology market, focusing on developing and manufacturing high-tech ophthalmic equipment. Moptim’s business model revolves around the in-house production and sale of these devices through a global distributor network to clients such as hospitals and eye care clinics. The company’s parent, Shenzhen Certain Technology Co., Ltd., handles the entire manufacturing process, which is certified for ISO 9001 and ISO 13485 quality standards.

The company's history is marked by significant technical achievements, starting with an early OCT prototype in 2003 and the development of China's first handheld OCT in 2006. A key milestone occurred in 2005 when Moptim partnered with Tsinghua University to create a corporate laboratory for the industrialization of OCT technology, a first in China. This collaboration has been central to its growth, positioning Moptim as a market leader for OCT devices in China and an expanding presence internationally. In 2023, the company entered into a strategic partnership with Carl Zeiss Vision China to co-develop new vision care solutions, and in 2024, it partnered with China Eye Valley to establish an ophthalmic equipment innovation research institute.

Moptim’s product portfolio is segmented into three main categories: Diagnostics, Refraction, and Surgical. The Diagnostics line includes advanced OCT and OCT Angiography (OCTA) systems like the Mocean 4000, which features high-speed scanning and real-time retinal tracking. This category also offers optical biometers, tonometers, slit lamps, and the DEA Dry Eye Analyzer. The Refraction segment provides devices to improve practice efficiency, such as the easyRef handheld auto-refractometer based on Shack-Hartmann wavefront technology and the iRef manual refractometer for at-home vision monitoring. The Surgical division offers operating microscopes, leveraging two decades of experience in manufacturing optical instruments.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2003
Headquarters
Shenzhen, China
Employees
17
Open positions
None listed
Dealroom signal
26.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Ophthalmology, Medical Imaging, Health Diagnostics, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Apr 2026 $14M $55M Guoke Chuangxin · China Venture Capital Fund · Baidu Ventures ↗
SERIES AEquity / VC Mar 2022 $1.4M $5.5M Baidu Ventures —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Moptim website traffic

Latest recorded traffic for Moptim is 290 monthly website visits, down 53.2% over the last three months. Moptim's team grew 6.3% over the past year.

Latest monthly visits290 3-month web change-53.2% 1-year team growth+6.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Baidu Ventures
  • China Venture Capital Fund
  • Guoke Chuangxin
Employees 17 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇨🇳 China45.5%
🇮🇹 Italy18.2%
🇲🇾 Malaysia9.1%
🇬🇧 United Kingdom9.1%
🇨🇦 Canada9.1%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Moptim on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Moptim’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.